{
    "paper_id": "PMC6420209",
    "metadata": {
        "title": "Principles for targeting RNA with drug-like small molecules",
        "authors": [
            {
                "first": "Katherine",
                "middle": [
                    "Deigan"
                ],
                "last": "Warner",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Christine",
                "middle": [
                    "E."
                ],
                "last": "Hajdin",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Kevin",
                "middle": [
                    "M."
                ],
                "last": "Weeks",
                "suffix": "",
                "email": "weeks@unc.edu",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "The vast majority of small-molecule therapeutics in clinical use target proteins. Successful protein-targeted drugs include small molecules that bind proteins expressed by humans (Fig. 1) or those expressed by bacteria, viruses and other infectious organisms. If small-molecule therapeutics could be extended to modulate RNA, the landscape of targetable macromolecules would be expanded by more than an order of magnitude. For example, only roughly 1.5% of the human genome encodes proteins1,2. Within the roughly 20,000 expressed human proteins, 10\u201315% of these are thought to be disease-related3,4,5, meaning that disrupting or altering their activity is likely to have a therapeutically useful consequence. Within the group of disease-related proteins, many are termed 'undruggable', meaning that these molecules lack distinctive cleft-like motifs into which small molecules can bind with high specificity and affinity5. The net implication of this analysis is that de novo human-designed small-molecule drugs target a sliver (the 3.5% of drugged proteins) of a sliver (1.5% of the human genome that encodes proteins) of the human genome. Currently approved protein-targeted drugs interact therapeutically with fewer than 700 gene products6, meaning that only 0.05% of the human genome has been drugged (Fig. 1).",
            "cite_spans": [
                {
                    "start": 490,
                    "end": 491,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 492,
                    "end": 493,
                    "mention": "2",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 596,
                    "end": 597,
                    "mention": "3",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 598,
                    "end": 599,
                    "mention": "4",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 600,
                    "end": 601,
                    "mention": "5",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 921,
                    "end": 922,
                    "mention": "5",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 1242,
                    "end": 1243,
                    "mention": "6",
                    "ref_id": "BIBREF64"
                }
            ],
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 180,
                    "end": 186,
                    "mention": "Fig. 1",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 1307,
                    "end": 1313,
                    "mention": "Fig. 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "RNA functions as a central conduit of information transfer in all biological systems7,8 and, in principle, there are numerous opportunities for creating small-molecule therapeutics targeting RNA. If mRNAs could be targeted, protein gene products could be modulated by upregulating or downregulating translation efficiency or by altering mRNA abundance or stability. By directly targeting mRNAs, activities of proteins that are very difficult to drug or undruggable might be modulated before or during their biogenesis. In addition, a large fraction of the human genome (~70%) is transcribed into non-coding RNAs (RNAs that function directly as RNA)9 (Fig. 1). One class of non-coding RNAs, microRNAs, are now well-validated therapeutic targets10,11. Humans probably produce more than 15,000 long non-coding RNAs12, and a subset of these may eventually prove to be good drug targets. In summary, if a fraction of the tens of thousands of mRNAs and non-coding RNAs were targetable, the extent of the druggable human genome could increase considerably.",
            "cite_spans": [
                {
                    "start": 84,
                    "end": 85,
                    "mention": "7",
                    "ref_id": "BIBREF75"
                },
                {
                    "start": 86,
                    "end": 87,
                    "mention": "8",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 648,
                    "end": 649,
                    "mention": "9",
                    "ref_id": "BIBREF97"
                },
                {
                    "start": 743,
                    "end": 745,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 746,
                    "end": 748,
                    "mention": "11",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 811,
                    "end": 813,
                    "mention": "12",
                    "ref_id": "BIBREF12"
                }
            ],
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 651,
                    "end": 657,
                    "mention": "Fig. 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Strong proof of principle for RNA-targeted drugs has been provided by experiments and clinical trials using antisense oligonucleotides (several of which have gained regulatory approval), as well as preclinical studies with synthetic RNAs that redirect the cellular RNA interference (RNAi) machinery or that activate CRISPR-based systems10,11,13,14,15,16. Depending on the approach employed, it is possible to inhibit or to upregulate expression13,14 of particular mRNAs and to inhibit non-coding RNA function by targeting specific RNA sequences. However, these nucleic-acid-based approaches involve large, often highly charged molecules and present delivery challenges. Given the choice between an oligonucleotide-based therapy and a (currently hypothetical) small-molecule-based therapy that targets RNA, the small-molecule therapy would be preferred in many cases.",
            "cite_spans": [
                {
                    "start": 336,
                    "end": 338,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 339,
                    "end": 341,
                    "mention": "11",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 342,
                    "end": 344,
                    "mention": "13",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 345,
                    "end": 347,
                    "mention": "14",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 348,
                    "end": 350,
                    "mention": "15",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 351,
                    "end": 353,
                    "mention": "16",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 444,
                    "end": 446,
                    "mention": "13",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 447,
                    "end": 449,
                    "mention": "14",
                    "ref_id": "BIBREF14"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "A number of small molecules that alter RNA function have been identified, providing encouraging evidence that RNA-targeted small-molecule therapeutics could be developed. Some of these studies are based on molecules identified in natural systems. For example, many RNA riboswitch regulatory elements that bind diverse small-molecule metabolites and regulate gene expression have been characterized17, and small-molecule antibiotics produced by numerous bacterial species bind ribosomal RNA and interfere with translation18. Furthermore, a growing number of synthetic monovalent and multivalent molecules that bind to secondary structure elements or repeat-containing RNAs have been shown to modulate biological function19. This progress is helping to address scepticism that RNA could be a viable small-molecule drug target, but key challenges remain to be addressed.",
            "cite_spans": [
                {
                    "start": 397,
                    "end": 399,
                    "mention": "17",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 520,
                    "end": 522,
                    "mention": "18",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 719,
                    "end": 721,
                    "mention": "19",
                    "ref_id": "BIBREF19"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Any discussion of how to target RNA with small molecules needs to immediately acknowledge that no one currently knows how to create drug-like, RNA-targeted small molecules in a repeatable and scalable way. There is currently only a single human-designed and approved drug class that functions by binding RNA alone \u2014 the linezolid antibiotics, linezolid and tedizolid (Fig. 2). In our view, successful targeting of RNA in therapeutically useful ways with small molecules requires three distinct components: (1) identification of RNAs and RNA motifs with disease-related function, (2) use of screening approaches and libraries likely to identify drug-like molecules with appropriate pharmacological properties and (3) identification of and focus on RNA motifs with sufficient structural sophistication that make it likely that high affinity and specificity in small-molecule binding can be achieved. To date, most work has focused on therapeutically well-validated targets (component 1), and there has been a notable recent focus on screening against RNA targets with drug-like lead compounds (component 2). However \u2014 and critically in our view \u2014 considerations of target complexity and achievable selectivity (component 3) have been largely neglected. With this in mind, after overviewing the current state of small-molecule ligand discovery for RNA targets and some instructional examples, we present a set of hypotheses regarding how to target RNA with small molecules and guidelines for achieving this goal. This article is intended to be provocative, and we look forward to the feedback and responses that our ideas will engender.",
            "cite_spans": [],
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 368,
                    "end": 374,
                    "mention": "Fig. 2",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "We first reiterate that no one currently knows how to target RNA with drug-like small molecules in a scalable and reproducible way. Proof-of-principle examples exist (Figs. 2,3), but the most drug-like of these molecules were discovered based on phenotypic assays and were only later found to target RNA. The molecules discovered to date via strategies intentionally designed to target RNA generally suffer from trade-offs in drug-likeness and potency due to low information content and low pocket quality. Nonetheless, current examples are supportive of the fundamental targetability of RNA. We suspect that a wide variety of screening strategies \u2014 including phenotypic assays, high-throughput screening, fragment-based screening, small-molecule microarrays, other biophysical partitioning approaches, and structure-inspired and computationally assisted design \u2014 will eventually prove useful. In this light, we would like to propose the following guidelines for future efforts directed at RNA-targeted drug discovery.",
            "cite_spans": [],
            "section": "Provocative guidelines",
            "ref_spans": [
                {
                    "start": 167,
                    "end": 174,
                    "mention": "Figs. 2",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 175,
                    "end": 176,
                    "mention": "3",
                    "ref_id": "FIGREF2"
                }
            ]
        },
        {
            "text": "\u2022 Focus on RNA motifs of sufficient complexity that they will be unique, able to form high-quality pockets and capable of binding small-molecule ligands with high affinity. We think that good RNA targets should have 30 bits and a pocket. Such motifs are likely to be common in large RNAs. We posit that few good targetable pockets exist in the absence of high information content.",
            "cite_spans": [],
            "section": "Provocative guidelines",
            "ref_spans": []
        },
        {
            "text": "\u2022 Be cautious of early attempts to define specialized privileged chemical scaffolds for targeting RNA. These might exist, but a lot more information is likely to be required before promising scaffolds can be defined. Instead, emphasize rules derived from decades of development of protein-targeted drugs. Most are likely to apply to RNA-targeted drugs as well.",
            "cite_spans": [],
            "section": "Provocative guidelines",
            "ref_spans": []
        },
        {
            "text": "\u2022 De-emphasize 'lessons' from the ribosome. Due to their uniquely high concentration in cells, ribosomal RNAs are a special case. The only engagement expected for a ligand with micromolar affinity is a target that is present at micromolar concentration. Drugs targeting ribosomal RNAs thus achieve a unique kind of specificity by binding relatively weakly to the ribosome.",
            "cite_spans": [],
            "section": "Provocative guidelines",
            "ref_spans": []
        },
        {
            "text": "\u2022 Be cautious in interpreting the results of studies focused on compounds that are highly basic, intercalating, strongly stacking and/or highly hydrophobic. These kinds of compounds may bind RNA with high affinity but are unlikely to show strong discrimination between target and off-target sites and are likely to be difficult to improve in a medicinal chemistry campaign.",
            "cite_spans": [],
            "section": "Provocative guidelines",
            "ref_spans": []
        },
        {
            "text": "\u2022 Target RNA\u2013protein interactions or RNA elements stabilized by protein binding, as branaplam and SMA-C5 appear to do32,33. It is easy to imagine that recognition of a target-specific RNA element in conjunction with a general protein component of cellular metabolism or regulatory network might be a highly productive strategy for achieving both specificity (via a selective RNA-targeted component) and affinity (owing to the high information content of a protein interface).",
            "cite_spans": [
                {
                    "start": 117,
                    "end": 119,
                    "mention": "32",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 120,
                    "end": 122,
                    "mention": "33",
                    "ref_id": "BIBREF35"
                }
            ],
            "section": "Provocative guidelines",
            "ref_spans": []
        },
        {
            "text": "\u2022 Use methods that enable rapid identification of RNA motifs with high-information-content structures and high-quality pockets. A clear advantage of RNA over proteins is that tools, such as quantitative chemical probing approaches55,75,87, already exist that make it possible to identify high-information-content72,73 and structurally well-determined (low-entropy) target sites54,55, to examine the influence of the cellular environment on a specific RNA structure and to ensure that simplified screening constructs recapitulate the native RNA motif.",
            "cite_spans": [
                {
                    "start": 230,
                    "end": 232,
                    "mention": "55",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 233,
                    "end": 235,
                    "mention": "75",
                    "ref_id": "BIBREF81"
                },
                {
                    "start": 236,
                    "end": 238,
                    "mention": "87",
                    "ref_id": "BIBREF94"
                },
                {
                    "start": 312,
                    "end": 314,
                    "mention": "72",
                    "ref_id": "BIBREF78"
                },
                {
                    "start": 315,
                    "end": 317,
                    "mention": "73",
                    "ref_id": "BIBREF79"
                },
                {
                    "start": 377,
                    "end": 379,
                    "mention": "54",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 380,
                    "end": 382,
                    "mention": "55",
                    "ref_id": "BIBREF59"
                }
            ],
            "section": "Provocative guidelines",
            "ref_spans": []
        },
        {
            "text": "\u2022 Develop additional tools and new refinements of current tools, including advanced structural biology and modelling strategies for RNAs with complex structures88,89,90. These technologies can then be leveraged to identify and rapidly characterize the subset of complex RNA structures with high-quality ligand-binding pockets and to rapidly assess the impact of ligand binding on the functions of these sites.",
            "cite_spans": [
                {
                    "start": 160,
                    "end": 162,
                    "mention": "88",
                    "ref_id": "BIBREF95"
                },
                {
                    "start": 163,
                    "end": 165,
                    "mention": "89",
                    "ref_id": "BIBREF96"
                },
                {
                    "start": 166,
                    "end": 168,
                    "mention": "90",
                    "ref_id": "BIBREF98"
                }
            ],
            "section": "Provocative guidelines",
            "ref_spans": []
        },
        {
            "text": "\u2022 Implement reproducible strategies for connecting ligand binding to complex targets with clear therapeutic mechanisms. There is modest-to-good evidence that disrupting or stabilizing RNA structures near translation initiation sites can modulate gene expression in therapeutically useful ways13,64,91. There is some evidence that the binding of small molecules to mRNAs can modulate the efficiency of translation92,93. Both disrupting and stabilizing RNA\u2013protein interactions are therapeutically promising. Covalent drugs are gaining acceptance in the protein-targeting field; analogously, ligands that can form covalent linkages or induce cleavage at an RNA target site44,94 also hold promise.",
            "cite_spans": [
                {
                    "start": 292,
                    "end": 294,
                    "mention": "13",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 295,
                    "end": 297,
                    "mention": "64",
                    "ref_id": "BIBREF69"
                },
                {
                    "start": 298,
                    "end": 300,
                    "mention": "91",
                    "ref_id": "BIBREF99"
                },
                {
                    "start": 412,
                    "end": 414,
                    "mention": "92",
                    "ref_id": "BIBREF100"
                },
                {
                    "start": 415,
                    "end": 417,
                    "mention": "93",
                    "ref_id": "BIBREF101"
                },
                {
                    "start": 670,
                    "end": 672,
                    "mention": "44",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 673,
                    "end": 675,
                    "mention": "94",
                    "ref_id": "BIBREF102"
                }
            ],
            "section": "Provocative guidelines",
            "ref_spans": []
        },
        {
            "text": "Three key components are necessary to enable effective, repeatable and scalable RNA-targeted drug discovery: (1) a therapeutically compelling RNA target, (2) a screening approach that will identify drug-like lead molecules with appropriate pharmacological properties and (3) the identification of RNA motifs with sufficient information content such that high-specificity and high-potency binding to a high-quality pocket is achieved. We are arguing for a broad change in strategy for creating RNA-targeted drugs. Much greater emphasis needs to be placed on the quality of the RNA target (component 3). Biologically well-validated RNA targets are important, of course, but much greater effort needs to be placed on ensuring the 'ligandability' of these targets. Ultimately, as we learn more about what constitutes a high-quality RNA target, RNA might prove to be no more difficult to drug than proteins. Indeed, given that targetable RNA motifs appear to be ubiquitous (Refs 17, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66 and Fig. 7d,e) and that the principles of RNA structure and folding are simpler than those for proteins95, we wonder if RNA might eventually prove to be more generically targetable than proteins. Success of RNA-targeted therapeutic discovery efforts would open up vast opportunities (Fig. 1) for modulating the functions of currently undruggable protein-mediated pathways and the non-coding transcriptome.",
            "cite_spans": [
                {
                    "start": 974,
                    "end": 976,
                    "mention": "17",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 978,
                    "end": 980,
                    "mention": "54",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 982,
                    "end": 984,
                    "mention": "55",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 986,
                    "end": 988,
                    "mention": "56",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 990,
                    "end": 992,
                    "mention": "57",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 994,
                    "end": 996,
                    "mention": "58",
                    "ref_id": "BIBREF62"
                },
                {
                    "start": 998,
                    "end": 1000,
                    "mention": "59",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 1002,
                    "end": 1004,
                    "mention": "60",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 1006,
                    "end": 1008,
                    "mention": "61",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 1010,
                    "end": 1012,
                    "mention": "62",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 1014,
                    "end": 1016,
                    "mention": "63",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 1018,
                    "end": 1020,
                    "mention": "64",
                    "ref_id": "BIBREF69"
                },
                {
                    "start": 1022,
                    "end": 1024,
                    "mention": "65",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 1026,
                    "end": 1028,
                    "mention": "66",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 1132,
                    "end": 1134,
                    "mention": "95",
                    "ref_id": "BIBREF103"
                }
            ],
            "section": "Perspective",
            "ref_spans": [
                {
                    "start": 1033,
                    "end": 1042,
                    "mention": "Fig. 7d,e",
                    "ref_id": "FIGREF6"
                },
                {
                    "start": 1313,
                    "end": 1319,
                    "mention": "Fig. 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.",
            "cite_spans": [],
            "section": "Publisher's note",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Figure 1: Only a small fraction of the human genome has been successfully drugged to date. As shown in the pie chart, only ~1.5% of the genome encodes proteins (corresponding to ~20,000 proteins)1,2. As shown in the expanded pie segment above, an estimated 10\u201315% of proteins are thought to be disease-related3,4,5 (~2,000\u20133,000 proteins; encoded by 0.2% of the genome). Currently approved drugs interact therapeutically with <700 of these proteins (encoded by 0.05% of the human genome)6. Targeting RNAs could expand on the proportion of the human genome that could be therapeutically targeted. Possible RNA targets include mRNAs that encode disease-related proteins that have been characterized as undruggable or difficult to drug (shown in light blue in the pie segment) and also non-coding RNAs that influence disease (corresponding to an unknown proportion of the ~70% of the genome that encodes non-coding RNAs). \nPowerPoint slide\n",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Figure 2: a | Molecules that bind RNA tertiary structures. Molecules are listed by their quantitative estimate of drug-likeness (QED) score (Box 1), with the most drug-like molecules towards the top and towards the left if the molecules are on the same row. The equilibrium dissociation constant (Kd) is listed for most molecules; if no Kd was available, the median inhibitory concentration (IC50) is provided instead (indicated by an asterisk). Molecular properties were calculated with SilicosIT. b | Relationship between QED scores and RNA binding affinity. Molecules targeting tertiary structures (shown in this figure; 3D targets) and those targeting secondary and repeat structures (from Fig. 3; 2D and 2DREP targets) are shown as circles, squares and diamonds, respectively. The green box highlights the region where most (five out of six) molecules that target RNA tertiary structures fall. The dashed blue curve highlights a trend for molecules targeting RNA secondary structures and repeat sequences: molecules with greater potency tend to have lower drug-likeness. FMN, flavin mononucleotide; rRNA, ribosomal RNA; SMN2, survival motor neuron protein. \nPowerPoint slide\n",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Figure 3: Molecules that bind RNA secondary structures (part a) and trinucleotide repeats (part b). Molecules are listed by their quantitative estimate of drug-likeness (QED) score, with the most drug-like molecules towards the top and towards the left if the molecules are on the same row. The equilibrium dissociation constant (Kd) is listed for most molecules; if no Kd was available, the median inhibitory concentration (IC50) is provided instead (indicated by an asterisk). HCV IRES, hepatitis C virus internal ribosome entry site; Kd, equilibrium dissociation constant; pre-miR, pre-microRNA; RRE, Rev response element; TAR, transactivation response. \nPowerPoint slide\n",
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Figure 4: Both linezolid and ribocil have high quantitative estimate of drug-likeness (QED) scores27 and are bound within cleft-like sites29,30 composed of first-sphere nucleotides in contact with the ligand (green) supported by second-sphere nucleotides (grey). These motifs have high information content. IC50, median inhibitory concentration; Kd, equilibrium dissociation constant; logP, octanol\u2013water partition coefficient; Mr, relative molecular mass; tPSA, total polar surface area. \nPowerPoint slide\n",
            "type": "figure"
        },
        "FIGREF4": {
            "text": "Figure 5: Molecular interactions of riboflavin (blue) with riboflavin kinase protein (Protein Data Bank (PDB) identifier: inb9)69 (left) and flavin mononucleotide (FMN) riboswitch RNA (PDB ID: 3f4g)70 (right). Hydrogen bonds are shown with green dashed lines, and van der Waals and stacking interactions are emphasized with red arcs. Water molecules and metal ions are shown as cyan and green spheres, respectively. Riboflavin has a molecular mass of 376 Da, an octanol\u2013water partition coefficient of \u22120.76, a total polar surface area of 162 and a quantitative estimate of drug-likeness score of 0.33. Bottom images were initially drafted with LigPlot+. \nPowerPoint slide\n",
            "type": "figure"
        },
        "FIGREF5": {
            "text": "Figure 6: The solid and dashed lines show the relationship between RNA target information content and binding affinity for GTP (circles) and targaprimir-96 (diamonds) (based on data from Refs 73, 78). Simple helices are assigned 9 \u00b1 2 bits of information. Ribocil30 and branaplam32 are estimated to have \u226550 bits of information and are placed on a separate scale on the right. Binding data for low- and medium-complexity targets (squares) are from the following: influenza A promoter stem-loop (20 bits)49, transactivation response (TAR) (22 bits)37,39,40,48, hepatitis C virus internal ribosome entry site (HCV IRES) bulged-stem (26 bits)36,41,102 and severe acute respiratory syndrome (SARS) pseudoknot (30 bits)47,101. \nPowerPoint slide\n",
            "type": "figure"
        },
        "FIGREF6": {
            "text": "Figure 7: Structures are coloured by pocket quality, with larger and more buried pockets ranking higher. a | Riboflavin binding pockets for protein (Protein Data Bank (PDB) identifier: 1nb9)69 and RNA (PDB ID: 3f4g)70 targets. Macromolecular targets are the same as those shown in Fig. 5. b | Pocket for linezolid in the Escherichia coli 23S ribosomal RNA (rRNA) (PDB ID: 3dll)29. c | Ligand-binding pockets in representative low-to-medium-complexity targets including a CAG helical repeat (PDB ID: 4j50)104, stem-loop (PDB ID: 1oq0)105, microRNA (miR; PDB ID: 2n7x)106 and HIV transactivation response (TAR) (PDB ID: 1qd3)107 and Rev response element (RRE) (PDB ID: 1i9f)108. d,e | Potential ligand-binding pockets in high complexity sites: three-helix junctions (PDB ID: 2mtj and 2n3r)82,83 and the simian retrovirus type 1 (SRV-1) pseudoknot (PDB ID: 1e95)85. Pocket qualities were calculated using Pocket-Finder81, as part of the MolSoft package. FMN, flavin mononucleotide. \nPowerPoint slide\n",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Distinguishing protein-coding and noncoding genes in the human genome",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Clamp",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Proc. Natl Acad. Sci. USA",
            "volume": "104",
            "issn": "",
            "pages": "19428-19433",
            "other_ids": {
                "DOI": [
                    "10.1073/pnas.0709013104"
                ]
            }
        },
        "BIBREF1": {
            "title": "Non-coding RNAs as drug targets",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Matsui",
                    "suffix": ""
                },
                {
                    "first": "DR",
                    "middle": [],
                    "last": "Corey",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Nat. Rev. Drug Discov.",
            "volume": "16",
            "issn": "",
            "pages": "167-179",
            "other_ids": {
                "DOI": [
                    "10.1038/nrd.2016.117"
                ]
            }
        },
        "BIBREF2": {
            "title": "The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin",
            "authors": [
                {
                    "first": "AH",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "RW",
                    "middle": [],
                    "last": "Murray",
                    "suffix": ""
                },
                {
                    "first": "TJ",
                    "middle": [],
                    "last": "Vidmar",
                    "suffix": ""
                },
                {
                    "first": "KR",
                    "middle": [],
                    "last": "Marotti",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Antimicrob. Agents Chemother.",
            "volume": "41",
            "issn": "",
            "pages": "2127-2131",
            "other_ids": {
                "DOI": [
                    "10.1128/AAC.41.10.2127"
                ]
            }
        },
        "BIBREF3": {
            "title": "Anti-frameshifting ligand reduces the conformational plasticity of the SARS virus pseudoknot",
            "authors": [
                {
                    "first": "DB",
                    "middle": [],
                    "last": "Ritchie",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Soong",
                    "suffix": ""
                },
                {
                    "first": "WKA",
                    "middle": [],
                    "last": "Sikkema",
                    "suffix": ""
                },
                {
                    "first": "MT",
                    "middle": [],
                    "last": "Woodside",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J. Am. Chem. Soc.",
            "volume": "136",
            "issn": "",
            "pages": "2196-2199",
            "other_ids": {
                "DOI": [
                    "10.1021/ja410344b"
                ]
            }
        },
        "BIBREF4": {
            "title": "Conformational inhibition of the hepatitis C virus internal ribosome entry site RNA",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Parsons",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Nat. Chem. Biol.",
            "volume": "5",
            "issn": "",
            "pages": "823-825",
            "other_ids": {
                "DOI": [
                    "10.1038/nchembio.217"
                ]
            }
        },
        "BIBREF5": {
            "title": "Small molecule inhibition of microRNA-210 reprograms an oncogenic hypoxic circuit",
            "authors": [
                {
                    "first": "MG",
                    "middle": [],
                    "last": "Costales",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "J. Am. Chem. Soc.",
            "volume": "139",
            "issn": "",
            "pages": "3446-3455",
            "other_ids": {
                "DOI": [
                    "10.1021/jacs.6b11273"
                ]
            }
        },
        "BIBREF6": {
            "title": "A dynamic structural model of expanded RNA CAG repeats: a refined X-ray structure and computational investigations using molecular dynamics and umbrella sampling simulations",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Yildirim",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Park",
                    "suffix": ""
                },
                {
                    "first": "MD",
                    "middle": [],
                    "last": "Disney",
                    "suffix": ""
                },
                {
                    "first": "GC",
                    "middle": [],
                    "last": "Schatz",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J. Am. Chem. Soc.",
            "volume": "135",
            "issn": "",
            "pages": "3528-3538",
            "other_ids": {
                "DOI": [
                    "10.1021/ja3108627"
                ]
            }
        },
        "BIBREF7": {
            "title": "The solution structure of an essential stem-loop of human telomerase RNA",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Leeper",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Leulliot",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Varani",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Nucleic Acids Res.",
            "volume": "31",
            "issn": "",
            "pages": "2614-2621",
            "other_ids": {
                "DOI": [
                    "10.1093/nar/gkg351"
                ]
            }
        },
        "BIBREF8": {
            "title": "Rbfox proteins regulate microRNA biogenesis by sequence-specific binding to their precursors and target downstream Dicer",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Nucleic Acids Res.",
            "volume": "44",
            "issn": "",
            "pages": "4381-4395",
            "other_ids": {
                "DOI": [
                    "10.1093/nar/gkw177"
                ]
            }
        },
        "BIBREF9": {
            "title": "Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Faber",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Sticht",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Schweimer",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "R\u00f6sch",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "J. Biol. Chem.",
            "volume": "275",
            "issn": "",
            "pages": "20660-20666",
            "other_ids": {
                "DOI": [
                    "10.1074/jbc.M000920200"
                ]
            }
        },
        "BIBREF10": {
            "title": "Structural characterization of the complex of the Rev response element RNA with a selected peptide",
            "authors": [
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Harada",
                    "suffix": ""
                },
                {
                    "first": "HS",
                    "middle": [],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "AD",
                    "middle": [],
                    "last": "Frankel",
                    "suffix": ""
                },
                {
                    "first": "DE",
                    "middle": [],
                    "last": "Wemmer",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Chem. Biol.",
            "volume": "8",
            "issn": "",
            "pages": "511-520",
            "other_ids": {
                "DOI": [
                    "10.1016/S1074-5521(01)00027-8"
                ]
            }
        },
        "BIBREF11": {
            "title": "Targeting noncoding RNAs in disease",
            "authors": [
                {
                    "first": "BD",
                    "middle": [],
                    "last": "Adams",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Parsons",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Walker",
                    "suffix": ""
                },
                {
                    "first": "WC",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "FJ",
                    "middle": [],
                    "last": "Slack",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "J. Clin. Invest.",
            "volume": "127",
            "issn": "",
            "pages": "761-771",
            "other_ids": {
                "DOI": [
                    "10.1172/JCI84424"
                ]
            }
        },
        "BIBREF12": {
            "title": "GENCODE: the reference human genome annotation for The ENCODE Project",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Harrow",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Genome Res.",
            "volume": "22",
            "issn": "",
            "pages": "1760-1774",
            "other_ids": {
                "DOI": [
                    "10.1101/gr.135350.111"
                ]
            }
        },
        "BIBREF13": {
            "title": "Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading frames",
            "authors": [
                {
                    "first": "X-H",
                    "middle": [],
                    "last": "Liang",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Nat. Biotechnol.",
            "volume": "34",
            "issn": "",
            "pages": "875-880",
            "other_ids": {
                "DOI": [
                    "10.1038/nbt.3589"
                ]
            }
        },
        "BIBREF14": {
            "title": "Antisense oligonucleotides targeting translation inhibitory elements in 5\u2032 UTRs can selectively increase protein levels",
            "authors": [
                {
                    "first": "X-H",
                    "middle": [],
                    "last": "Liang",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Nucleic Acids Res.",
            "volume": "45",
            "issn": "",
            "pages": "9528-9546",
            "other_ids": {
                "DOI": [
                    "10.1093/nar/gkx632"
                ]
            }
        },
        "BIBREF15": {
            "title": "RNA-targeted therapeutics",
            "authors": [
                {
                    "first": "ST",
                    "middle": [],
                    "last": "Crooke",
                    "suffix": ""
                },
                {
                    "first": "JL",
                    "middle": [],
                    "last": "Witztum",
                    "suffix": ""
                },
                {
                    "first": "CF",
                    "middle": [],
                    "last": "Bennett",
                    "suffix": ""
                },
                {
                    "first": "BF",
                    "middle": [],
                    "last": "Baker",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Cell Metab.",
            "volume": "27",
            "issn": "",
            "pages": "714-739",
            "other_ids": {
                "DOI": [
                    "10.1016/j.cmet.2018.03.004"
                ]
            }
        },
        "BIBREF16": {
            "title": "Cornerstones of CRISPR-Cas in drug discovery and therapy",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Fellmann",
                    "suffix": ""
                },
                {
                    "first": "BG",
                    "middle": [],
                    "last": "Gowen",
                    "suffix": ""
                },
                {
                    "first": "P-C",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "JA",
                    "middle": [],
                    "last": "Doudna",
                    "suffix": ""
                },
                {
                    "first": "JE",
                    "middle": [],
                    "last": "Corn",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Nat. Rev. Drug Discov.",
            "volume": "16",
            "issn": "",
            "pages": "89-100",
            "other_ids": {
                "DOI": [
                    "10.1038/nrd.2016.238"
                ]
            }
        },
        "BIBREF17": {
            "title": "Riboswitch diversity and distribution",
            "authors": [
                {
                    "first": "PJ",
                    "middle": [],
                    "last": "McCown",
                    "suffix": ""
                },
                {
                    "first": "KA",
                    "middle": [],
                    "last": "Corbino",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Stav",
                    "suffix": ""
                },
                {
                    "first": "ME",
                    "middle": [],
                    "last": "Sherlock",
                    "suffix": ""
                },
                {
                    "first": "RR",
                    "middle": [],
                    "last": "Breaker",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "RNA",
            "volume": "23",
            "issn": "",
            "pages": "995-1011",
            "other_ids": {
                "DOI": [
                    "10.1261/rna.061234.117"
                ]
            }
        },
        "BIBREF18": {
            "title": "Ribosome-targeting antibiotics and mechanisms of bacterial resistance",
            "authors": [
                {
                    "first": "DN",
                    "middle": [],
                    "last": "Wilson",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Nat. Rev. Microbiol.",
            "volume": "12",
            "issn": "",
            "pages": "35-48",
            "other_ids": {
                "DOI": [
                    "10.1038/nrmicro3155"
                ]
            }
        },
        "BIBREF19": {
            "title": "Approaches to validate and manipulate RNA targets with small molecules in cells",
            "authors": [
                {
                    "first": "JL",
                    "middle": [],
                    "last": "Childs-Disney",
                    "suffix": ""
                },
                {
                    "first": "MD",
                    "middle": [],
                    "last": "Disney",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Annu. Rev. Pharmacol. Toxicol.",
            "volume": "56",
            "issn": "",
            "pages": "123-140",
            "other_ids": {
                "DOI": [
                    "10.1146/annurev-pharmtox-010715-103910"
                ]
            }
        },
        "BIBREF20": {
            "title": "Multiple evidence strands suggest that there may be as few as 19,000 human protein-coding genes",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Ezkurdia",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Hum. Mol. Genet.",
            "volume": "23",
            "issn": "",
            "pages": "5866-5878",
            "other_ids": {
                "DOI": [
                    "10.1093/hmg/ddu309"
                ]
            }
        },
        "BIBREF21": {
            "title": "Targeting RNA with small molecules",
            "authors": [
                {
                    "first": "JR",
                    "middle": [],
                    "last": "Thomas",
                    "suffix": ""
                },
                {
                    "first": "PJ",
                    "middle": [],
                    "last": "Hergenrother",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Chem. Rev.",
            "volume": "108",
            "issn": "",
            "pages": "1171-1224",
            "other_ids": {
                "DOI": [
                    "10.1021/cr0681546"
                ]
            }
        },
        "BIBREF22": {
            "title": "Strategies for the design of RNA-binding small molecules",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Aboul-ela",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Future Med. Chem.",
            "volume": "2",
            "issn": "",
            "pages": "93-119",
            "other_ids": {
                "DOI": [
                    "10.4155/fmc.09.149"
                ]
            }
        },
        "BIBREF23": {
            "title": "Recent advances in developing small molecules targeting RNA",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                },
                {
                    "first": "MD",
                    "middle": [],
                    "last": "Disney",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "ACS Chem. Biol.",
            "volume": "7",
            "issn": "",
            "pages": "73-86",
            "other_ids": {
                "DOI": [
                    "10.1021/cb200447r"
                ]
            }
        },
        "BIBREF24": {
            "title": "The emerging role of RNA as a therapeutic target for small molecules",
            "authors": [
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Connelly",
                    "suffix": ""
                },
                {
                    "first": "MH",
                    "middle": [],
                    "last": "Moon",
                    "suffix": ""
                },
                {
                    "first": "JS",
                    "middle": [],
                    "last": "Schneekloth",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Cell Chem. Biol.",
            "volume": "23",
            "issn": "",
            "pages": "1077-1090",
            "other_ids": {
                "DOI": [
                    "10.1016/j.chembiol.2016.05.021"
                ]
            }
        },
        "BIBREF25": {
            "title": "Discovery of key physicochemical, structural, and spatial properties of RNA-targeted bioactive ligands",
            "authors": [
                {
                    "first": "BS",
                    "middle": [],
                    "last": "Morgan",
                    "suffix": ""
                },
                {
                    "first": "JE",
                    "middle": [],
                    "last": "Forte",
                    "suffix": ""
                },
                {
                    "first": "RN",
                    "middle": [],
                    "last": "Culver",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "AE",
                    "middle": [],
                    "last": "Hargrove",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Angew. Chem. Int. Ed. Engl.",
            "volume": "56",
            "issn": "",
            "pages": "13498-13502",
            "other_ids": {
                "DOI": [
                    "10.1002/anie.201707641"
                ]
            }
        },
        "BIBREF26": {
            "title": "Small molecules targeting viral RNA",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Hermann",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Wiley Interdiscip. Rev. RNA",
            "volume": "7",
            "issn": "",
            "pages": "726-743",
            "other_ids": {
                "DOI": [
                    "10.1002/wrna.1373"
                ]
            }
        },
        "BIBREF27": {
            "title": "RNA as a small molecule druggable target",
            "authors": [
                {
                    "first": "NF",
                    "middle": [],
                    "last": "Rizvi",
                    "suffix": ""
                },
                {
                    "first": "GF",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Bioorg. Med. Chem. Lett.",
            "volume": "27",
            "issn": "",
            "pages": "5083-5088",
            "other_ids": {
                "DOI": [
                    "10.1016/j.bmcl.2017.10.052"
                ]
            }
        },
        "BIBREF28": {
            "title": "Quantifying the chemical beauty of drugs",
            "authors": [
                {
                    "first": "GR",
                    "middle": [],
                    "last": "Bickerton",
                    "suffix": ""
                },
                {
                    "first": "GV",
                    "middle": [],
                    "last": "Paolini",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Besnard",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Muresan",
                    "suffix": ""
                },
                {
                    "first": "AL",
                    "middle": [],
                    "last": "Hopkins",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Nat. Chem.",
            "volume": "4",
            "issn": "",
            "pages": "90-98",
            "other_ids": {
                "DOI": [
                    "10.1038/nchem.1243"
                ]
            }
        },
        "BIBREF29": {
            "title": "Linezolid: the first oxazolidinone antimicrobial",
            "authors": [
                {
                    "first": "RC",
                    "middle": [],
                    "last": "Moellering",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Ann. Intern. Med.",
            "volume": "138",
            "issn": "",
            "pages": "135-142",
            "other_ids": {
                "DOI": [
                    "10.7326/0003-4819-138-2-200301210-00015"
                ]
            }
        },
        "BIBREF30": {
            "title": "The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning",
            "authors": [
                {
                    "first": "DN",
                    "middle": [],
                    "last": "Wilson",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Proc. Natl Acad. Sci. USA",
            "volume": "105",
            "issn": "",
            "pages": "13339-13344",
            "other_ids": {
                "DOI": [
                    "10.1073/pnas.0804276105"
                ]
            }
        },
        "BIBREF31": {
            "title": "The druggable genome",
            "authors": [
                {
                    "first": "AL",
                    "middle": [],
                    "last": "Hopkins",
                    "suffix": ""
                },
                {
                    "first": "CR",
                    "middle": [],
                    "last": "Groom",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Nat. Rev. Drug Discov.",
            "volume": "1",
            "issn": "",
            "pages": "727-730",
            "other_ids": {
                "DOI": [
                    "10.1038/nrd892"
                ]
            }
        },
        "BIBREF32": {
            "title": "Selective small-molecule inhibition of an RNA structural element",
            "authors": [
                {
                    "first": "JA",
                    "middle": [],
                    "last": "Howe",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Nature",
            "volume": "526",
            "issn": "",
            "pages": "672-677",
            "other_ids": {
                "DOI": [
                    "10.1038/nature15542"
                ]
            }
        },
        "BIBREF33": {
            "title": "Atomic resolution mechanistic studies of ribocil: a highly selective unnatural ligand mimic of the E. coli FMN riboswitch",
            "authors": [
                {
                    "first": "JA",
                    "middle": [],
                    "last": "Howe",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "RNA Biol.",
            "volume": "13",
            "issn": "",
            "pages": "946-954",
            "other_ids": {
                "DOI": [
                    "10.1080/15476286.2016.1216304"
                ]
            }
        },
        "BIBREF34": {
            "title": "SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Palacino",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Nat. Chem. Biol.",
            "volume": "11",
            "issn": "",
            "pages": "511-517",
            "other_ids": {
                "DOI": [
                    "10.1038/nchembio.1837"
                ]
            }
        },
        "BIBREF35": {
            "title": "Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sivaramakrishnan",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Nat. Commun.",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1038/s41467-017-01559-4"
                ]
            }
        },
        "BIBREF36": {
            "title": "Crystal structure of human U1 snRNP, a small nuclear ribonucleoprotein particle, reveals the mechanism of 5\u2032 splice site recognition",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kondo",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Oubridge",
                    "suffix": ""
                },
                {
                    "first": "A-MM",
                    "middle": [],
                    "last": "van Roon",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Nagai",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "eLife",
            "volume": "4",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.7554/eLife.04986"
                ]
            }
        },
        "BIBREF37": {
            "title": "Small molecules in development for the treatment of spinal muscular atrophy",
            "authors": [
                {
                    "first": "AN",
                    "middle": [],
                    "last": "Calder",
                    "suffix": ""
                },
                {
                    "first": "EJ",
                    "middle": [],
                    "last": "Androphy",
                    "suffix": ""
                },
                {
                    "first": "KJ",
                    "middle": [],
                    "last": "Hodgetts",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "J. Med. Chem.",
            "volume": "59",
            "issn": "",
            "pages": "10067-10083",
            "other_ids": {
                "DOI": [
                    "10.1021/acs.jmedchem.6b00670"
                ]
            }
        },
        "BIBREF38": {
            "title": "SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain",
            "authors": [
                {
                    "first": "PP",
                    "middle": [],
                    "last": "Seth",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J. Med. Chem.",
            "volume": "48",
            "issn": "",
            "pages": "7099-7102",
            "other_ids": {
                "DOI": [
                    "10.1021/jm050815o"
                ]
            }
        },
        "BIBREF39": {
            "title": "Discovery of selective, small-molecule inhibitors of RNA complexes\u2014I. The Tat protein/TAR RNA complexes required for HIV-1 transcription",
            "authors": [
                {
                    "first": "HY",
                    "middle": [],
                    "last": "Mei",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Bioorg. Med. Chem.",
            "volume": "5",
            "issn": "",
            "pages": "1173-1184",
            "other_ids": {
                "DOI": [
                    "10.1016/S0968-0896(97)00064-3"
                ]
            }
        },
        "BIBREF40": {
            "title": "Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Prado",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Biochem. Pharmacol.",
            "volume": "107",
            "issn": "",
            "pages": "14-28",
            "other_ids": {
                "DOI": [
                    "10.1016/j.bcp.2016.02.007"
                ]
            }
        },
        "BIBREF41": {
            "title": "Identification of biologically active, HIV TAR RNA-binding small molecules using small molecule microarrays",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Sztuba-Solinska",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J. Am. Chem. Soc.",
            "volume": "136",
            "issn": "",
            "pages": "8402-8410",
            "other_ids": {
                "DOI": [
                    "10.1021/ja502754f"
                ]
            }
        },
        "BIBREF42": {
            "title": "How many drug targets are there?",
            "authors": [
                {
                    "first": "JP",
                    "middle": [],
                    "last": "Overington",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Al-Lazikani",
                    "suffix": ""
                },
                {
                    "first": "AL",
                    "middle": [],
                    "last": "Hopkins",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Nat. Rev. Drug Discov.",
            "volume": "5",
            "issn": "",
            "pages": "993-996",
            "other_ids": {
                "DOI": [
                    "10.1038/nrd2199"
                ]
            }
        },
        "BIBREF43": {
            "title": "Artificial nucleobase-amino acid conjugates: a new class of TAR RNA binding agents",
            "authors": [
                {
                    "first": "J-P",
                    "middle": [],
                    "last": "Joly",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Chemistry",
            "volume": "20",
            "issn": "",
            "pages": "2071-2079",
            "other_ids": {
                "DOI": [
                    "10.1002/chem.201303664"
                ]
            }
        },
        "BIBREF44": {
            "title": "A modular approach to synthetic RNA binders of the hepatitis C virus internal ribosome entry site",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Carnevali",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Parsons",
                    "suffix": ""
                },
                {
                    "first": "DL",
                    "middle": [],
                    "last": "Wyles",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Hermann",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Chembiochem",
            "volume": "11",
            "issn": "",
            "pages": "1364-1367",
            "other_ids": {
                "DOI": [
                    "10.1002/cbic.201000177"
                ]
            }
        },
        "BIBREF45": {
            "title": "HIV-1 frameshift RNA-targeted triazoles inhibit propagation of replication-competent and multi-drug-resistant HIV in human cells",
            "authors": [
                {
                    "first": "TA",
                    "middle": [],
                    "last": "Hilimire",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "ACS Chem. Biol.",
            "volume": "12",
            "issn": "",
            "pages": "1674-1682",
            "other_ids": {
                "DOI": [
                    "10.1021/acschembio.7b00052"
                ]
            }
        },
        "BIBREF46": {
            "title": "Modulation of the E. coli rpoH Temperature sensor with triptycene-based small molecules",
            "authors": [
                {
                    "first": "SA",
                    "middle": [],
                    "last": "Barros",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Yoon",
                    "suffix": ""
                },
                {
                    "first": "DM",
                    "middle": [],
                    "last": "Chenoweth",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Angew. Chem. Int. Ed. Engl.",
            "volume": "55",
            "issn": "",
            "pages": "8258-8261",
            "other_ids": {
                "DOI": [
                    "10.1002/anie.201601626"
                ]
            }
        },
        "BIBREF47": {
            "title": "Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Nguyen",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "J. Am. Chem. Soc.",
            "volume": "137",
            "issn": "",
            "pages": "14180-14189",
            "other_ids": {
                "DOI": [
                    "10.1021/jacs.5b09266"
                ]
            }
        },
        "BIBREF48": {
            "title": "A potent inhibitor of protein sequestration by expanded triplet (CUG) repeats that shows phenotypic improvements in a Drosophila model of myotonic dystrophy",
            "authors": [
                {
                    "first": "LM",
                    "middle": [],
                    "last": "Luu",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "ChemMedChem",
            "volume": "11",
            "issn": "",
            "pages": "1428-1435",
            "other_ids": {
                "DOI": [
                    "10.1002/cmdc.201600081"
                ]
            }
        },
        "BIBREF49": {
            "title": "A novel small-molecule binds to the influenza A virus RNA promoter and inhibits viral replication",
            "authors": [
                {
                    "first": "M-K",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Chem. Commun. (Camb.)",
            "volume": "50",
            "issn": "",
            "pages": "368-370",
            "other_ids": {
                "DOI": [
                    "10.1039/C3CC46973E"
                ]
            }
        },
        "BIBREF50": {
            "title": "Identification of RNA pseudoknot-binding ligand that inhibits the -1 ribosomal frameshifting of SARS-coronavirus by structure-based virtual screening",
            "authors": [
                {
                    "first": "S-J",
                    "middle": [],
                    "last": "Park",
                    "suffix": ""
                },
                {
                    "first": "Y-G",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "H-J",
                    "middle": [],
                    "last": "Park",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J. Am. Chem. Soc.",
            "volume": "133",
            "issn": "",
            "pages": "10094-10100",
            "other_ids": {
                "DOI": [
                    "10.1021/ja1098325"
                ]
            }
        },
        "BIBREF51": {
            "title": "Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble",
            "authors": [
                {
                    "first": "AC",
                    "middle": [],
                    "last": "Stelzer",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Nat. Chem. Biol.",
            "volume": "7",
            "issn": "",
            "pages": "553-559",
            "other_ids": {
                "DOI": [
                    "10.1038/nchembio.596"
                ]
            }
        },
        "BIBREF52": {
            "title": "Targeting influenza A virus RNA promoter",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bottini",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Chem. Biol. Drug Des.",
            "volume": "86",
            "issn": "",
            "pages": "663-673",
            "other_ids": {
                "DOI": [
                    "10.1111/cbdd.12534"
                ]
            }
        },
        "BIBREF53": {
            "title": "Identifying druggable disease-modifying gene products",
            "authors": [
                {
                    "first": "SJ",
                    "middle": [],
                    "last": "Dixon",
                    "suffix": ""
                },
                {
                    "first": "BR",
                    "middle": [],
                    "last": "Stockwell",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Curr. Opin. Chem. Biol.",
            "volume": "13",
            "issn": "",
            "pages": "549-555",
            "other_ids": {
                "DOI": [
                    "10.1016/j.cbpa.2009.08.003"
                ]
            }
        },
        "BIBREF54": {
            "title": "Targeting protein-protein interaction by small molecules",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Jin",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Fang",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Annu. Rev. Pharmacol. Toxicol.",
            "volume": "54",
            "issn": "",
            "pages": "435-456",
            "other_ids": {
                "DOI": [
                    "10.1146/annurev-pharmtox-011613-140028"
                ]
            }
        },
        "BIBREF55": {
            "title": "Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates",
            "authors": [
                {
                    "first": "BC",
                    "middle": [],
                    "last": "Doak",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Over",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Giordanetto",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kihlberg",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Chem. Biol.",
            "volume": "21",
            "issn": "",
            "pages": "1115-1142",
            "other_ids": {
                "DOI": [
                    "10.1016/j.chembiol.2014.08.013"
                ]
            }
        },
        "BIBREF56": {
            "title": "Cell permeability beyond the rule of 5",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Matsson",
                    "suffix": ""
                },
                {
                    "first": "BC",
                    "middle": [],
                    "last": "Doak",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Over",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kihlberg",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Adv. Drug Deliv. Rev.",
            "volume": "101",
            "issn": "",
            "pages": "42-61",
            "other_ids": {
                "DOI": [
                    "10.1016/j.addr.2016.03.013"
                ]
            }
        },
        "BIBREF57": {
            "title": "A journey in bioinspired supramolecular chemistry: from molecular tweezers to small molecules that target myotonic dystrophy",
            "authors": [
                {
                    "first": "SC",
                    "middle": [],
                    "last": "Zimmerman",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Beilstein J. Org. Chem.",
            "volume": "12",
            "issn": "",
            "pages": "125-138",
            "other_ids": {
                "DOI": [
                    "10.3762/bjoc.12.14"
                ]
            }
        },
        "BIBREF58": {
            "title": "Pervasive regulatory functions of mRNA structure revealed by high-resolution SHAPE probing",
            "authors": [
                {
                    "first": "AM",
                    "middle": [],
                    "last": "Mustoe",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Cell",
            "volume": "173",
            "issn": "",
            "pages": "181-195.e18",
            "other_ids": {
                "DOI": [
                    "10.1016/j.cell.2018.02.034"
                ]
            }
        },
        "BIBREF59": {
            "title": "RNA motif discovery by SHAPE and mutational profiling (SHAPE-MaP)",
            "authors": [
                {
                    "first": "NA",
                    "middle": [],
                    "last": "Siegfried",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Busan",
                    "suffix": ""
                },
                {
                    "first": "GM",
                    "middle": [],
                    "last": "Rice",
                    "suffix": ""
                },
                {
                    "first": "JAE",
                    "middle": [],
                    "last": "Nelson",
                    "suffix": ""
                },
                {
                    "first": "KM",
                    "middle": [],
                    "last": "Weeks",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Nat. Methods",
            "volume": "11",
            "issn": "",
            "pages": "959-965",
            "other_ids": {
                "DOI": [
                    "10.1038/nmeth.3029"
                ]
            }
        },
        "BIBREF60": {
            "title": "Functionally conserved architecture of hepatitis C virus RNA genomes",
            "authors": [
                {
                    "first": "DM",
                    "middle": [],
                    "last": "Mauger",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Proc. Natl Acad. Sci. USA",
            "volume": "112",
            "issn": "",
            "pages": "3692-3697",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF61": {
            "title": "The coding region of the HCV genome contains a network of regulatory RNA structures",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Pirakitikulr",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kohlway",
                    "suffix": ""
                },
                {
                    "first": "BD",
                    "middle": [],
                    "last": "Lindenbach",
                    "suffix": ""
                },
                {
                    "first": "AM",
                    "middle": [],
                    "last": "Pyle",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Mol. Cell",
            "volume": "62",
            "issn": "",
            "pages": "111-120",
            "other_ids": {
                "DOI": [
                    "10.1016/j.molcel.2016.01.024"
                ]
            }
        },
        "BIBREF62": {
            "title": "RNA structure duplications and flavivirus host adaptation",
            "authors": [
                {
                    "first": "SM",
                    "middle": [],
                    "last": "Villordo",
                    "suffix": ""
                },
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Carballeda",
                    "suffix": ""
                },
                {
                    "first": "CV",
                    "middle": [],
                    "last": "Filomatori",
                    "suffix": ""
                },
                {
                    "first": "AV",
                    "middle": [],
                    "last": "Gamarnik",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Trends Microbiol.",
            "volume": "24",
            "issn": "",
            "pages": "270-283",
            "other_ids": {
                "DOI": [
                    "10.1016/j.tim.2016.01.002"
                ]
            }
        },
        "BIBREF63": {
            "title": "Structural divergence creates new functional features in alphavirus genomes",
            "authors": [
                {
                    "first": "KM",
                    "middle": [],
                    "last": "Kutchko",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Nucleic Acids Res.",
            "volume": "46",
            "issn": "",
            "pages": "3657-3670",
            "other_ids": {
                "DOI": [
                    "10.1093/nar/gky012"
                ]
            }
        },
        "BIBREF64": {
            "title": "A comprehensive map of molecular drug targets",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Nat. Rev. Drug Discov.",
            "volume": "16",
            "issn": "",
            "pages": "19-34",
            "other_ids": {
                "DOI": [
                    "10.1038/nrd.2016.230"
                ]
            }
        },
        "BIBREF65": {
            "title": "Mapping and characterization of the minimal internal ribosome entry segment in the human c-myc mRNA 5\u2032 untranslated region",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Cencig",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Oncogene",
            "volume": "23",
            "issn": "",
            "pages": "267-277",
            "other_ids": {
                "DOI": [
                    "10.1038/sj.onc.1207017"
                ]
            }
        },
        "BIBREF66": {
            "title": "Pri-miR-17-92a transcript folds into a tertiary structure and autoregulates its processing",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chakraborty",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mehtab",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Patwardhan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Krishnan",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "RNA",
            "volume": "18",
            "issn": "",
            "pages": "1014-1028",
            "other_ids": {
                "DOI": [
                    "10.1261/rna.031039.111"
                ]
            }
        },
        "BIBREF67": {
            "title": "SHAPE reveals transcript-wide interactions, complex structural domains, and protein interactions across the Xist lncRNA in living cells",
            "authors": [
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Smola",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Proc. Natl Acad. Sci. USA",
            "volume": "113",
            "issn": "",
            "pages": "10322-10327",
            "other_ids": {
                "DOI": [
                    "10.1073/pnas.1600008113"
                ]
            }
        },
        "BIBREF68": {
            "title": "Impact of RNA structure on ZFP36L2 interaction with luteinizing hormone receptor mRNA",
            "authors": [
                {
                    "first": "CB",
                    "middle": [],
                    "last": "Ball",
                    "suffix": ""
                },
                {
                    "first": "AC",
                    "middle": [],
                    "last": "Solem",
                    "suffix": ""
                },
                {
                    "first": "RM",
                    "middle": [],
                    "last": "Meganck",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Laederach",
                    "suffix": ""
                },
                {
                    "first": "SBV",
                    "middle": [],
                    "last": "Ramos",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "RNA",
            "volume": "23",
            "issn": "",
            "pages": "1209-1223",
            "other_ids": {
                "DOI": [
                    "10.1261/rna.060467.116"
                ]
            }
        },
        "BIBREF69": {
            "title": "An RNA structure-mediated, posttranscriptional model of human \u03b1-1-antitrypsin expression",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Corley",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Proc. Natl Acad. Sci. USA",
            "volume": "114",
            "issn": "",
            "pages": "E10244-E10253",
            "other_ids": {
                "DOI": [
                    "10.1073/pnas.1706539114"
                ]
            }
        },
        "BIBREF70": {
            "title": "eIF3 targets cell-proliferation messenger RNAs for translational activation or repression",
            "authors": [
                {
                    "first": "ASY",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "PJ",
                    "middle": [],
                    "last": "Kranzusch",
                    "suffix": ""
                },
                {
                    "first": "JHD",
                    "middle": [],
                    "last": "Cate",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Nature",
            "volume": "522",
            "issn": "",
            "pages": "111-114",
            "other_ids": {
                "DOI": [
                    "10.1038/nature14267"
                ]
            }
        },
        "BIBREF71": {
            "title": "A G-rich motif in the lncRNA Braveheart interacts with a zinc-finger transcription factor to specify the cardiovascular lineage",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Xue",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Mol. Cell",
            "volume": "64",
            "issn": "",
            "pages": "37-50",
            "other_ids": {
                "DOI": [
                    "10.1016/j.molcel.2016.08.010"
                ]
            }
        },
        "BIBREF72": {
            "title": "Resistance to linezolid caused by modifications at its binding site on the ribosome",
            "authors": [
                {
                    "first": "KS",
                    "middle": [],
                    "last": "Long",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Vester",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Antimicrob. Agents Chemother.",
            "volume": "56",
            "issn": "",
            "pages": "603-612",
            "other_ids": {
                "DOI": [
                    "10.1128/AAC.05702-11"
                ]
            }
        },
        "BIBREF73": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF74": {
            "title": "Crystal structure of human riboflavin kinase reveals a beta barrel fold and a novel active site arch",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Karthikeyan",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Structure",
            "volume": "11",
            "issn": "",
            "pages": "265-273",
            "other_ids": {
                "DOI": [
                    "10.1016/S0969-2126(03)00024-8"
                ]
            }
        },
        "BIBREF75": {
            "title": "The centrality of RNA",
            "authors": [
                {
                    "first": "PA",
                    "middle": [],
                    "last": "Sharp",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Cell",
            "volume": "136",
            "issn": "",
            "pages": "577-580",
            "other_ids": {
                "DOI": [
                    "10.1016/j.cell.2009.02.007"
                ]
            }
        },
        "BIBREF76": {
            "title": "Coenzyme recognition and gene regulation by a flavin mononucleotide riboswitch",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Serganov",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "DJ",
                    "middle": [],
                    "last": "Patel",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Nature",
            "volume": "458",
            "issn": "",
            "pages": "233-237",
            "other_ids": {
                "DOI": [
                    "10.1038/nature07642"
                ]
            }
        },
        "BIBREF77": {
            "title": "Information content of binding sites on nucleotide sequences",
            "authors": [
                {
                    "first": "TD",
                    "middle": [],
                    "last": "Schneider",
                    "suffix": ""
                },
                {
                    "first": "GD",
                    "middle": [],
                    "last": "Stormo",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Gold",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ehrenfeucht",
                    "suffix": ""
                }
            ],
            "year": 1986,
            "venue": "J. Mol. Biol.",
            "volume": "188",
            "issn": "",
            "pages": "415-431",
            "other_ids": {
                "DOI": [
                    "10.1016/0022-2836(86)90165-8"
                ]
            }
        },
        "BIBREF78": {
            "title": "Specific RNA binding by Q beta coat protein",
            "authors": [
                {
                    "first": "GW",
                    "middle": [],
                    "last": "Witherell",
                    "suffix": ""
                },
                {
                    "first": "OC",
                    "middle": [],
                    "last": "Uhlenbeck",
                    "suffix": ""
                }
            ],
            "year": 1989,
            "venue": "Biochemistry",
            "volume": "28",
            "issn": "",
            "pages": "71-76",
            "other_ids": {
                "DOI": [
                    "10.1021/bi00427a011"
                ]
            }
        },
        "BIBREF79": {
            "title": "Informational complexity and functional activity of RNA structures",
            "authors": [
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Carothers",
                    "suffix": ""
                },
                {
                    "first": "SC",
                    "middle": [],
                    "last": "Oestreich",
                    "suffix": ""
                },
                {
                    "first": "JH",
                    "middle": [],
                    "last": "Davis",
                    "suffix": ""
                },
                {
                    "first": "JW",
                    "middle": [],
                    "last": "Szostak",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J. Am. Chem. Soc.",
            "volume": "126",
            "issn": "",
            "pages": "5130-5137",
            "other_ids": {
                "DOI": [
                    "10.1021/ja031504a"
                ]
            }
        },
        "BIBREF80": {
            "title": "Structural constraints identified with covariation analysis in ribosomal RNA",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Shang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ozer",
                    "suffix": ""
                },
                {
                    "first": "RR",
                    "middle": [],
                    "last": "Gutell",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "PLoS ONE",
            "volume": "7",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1371/journal.pone.0039383"
                ]
            }
        },
        "BIBREF81": {
            "title": "Exploring RNA structural codes with SHAPE chemistry",
            "authors": [
                {
                    "first": "KM",
                    "middle": [],
                    "last": "Weeks",
                    "suffix": ""
                },
                {
                    "first": "DM",
                    "middle": [],
                    "last": "Mauger",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Acc. Chem. Res.",
            "volume": "44",
            "issn": "",
            "pages": "1280-1291",
            "other_ids": {
                "DOI": [
                    "10.1021/ar200051h"
                ]
            }
        },
        "BIBREF82": {
            "title": "Selective 2\u2032-hydroxyl acylation analyzed by primer extension and mutational profiling (SHAPE-MaP) for direct, versatile and accurate RNA structure analysis",
            "authors": [
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Smola",
                    "suffix": ""
                },
                {
                    "first": "GM",
                    "middle": [],
                    "last": "Rice",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Busan",
                    "suffix": ""
                },
                {
                    "first": "NA",
                    "middle": [],
                    "last": "Siegfried",
                    "suffix": ""
                },
                {
                    "first": "KM",
                    "middle": [],
                    "last": "Weeks",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Nat. Protoc.",
            "volume": "10",
            "issn": "",
            "pages": "1643-1669",
            "other_ids": {
                "DOI": [
                    "10.1038/nprot.2015.103"
                ]
            }
        },
        "BIBREF83": {
            "title": "Solution structure of an informationally complex high-affinity RNA aptamer to GTP",
            "authors": [
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Carothers",
                    "suffix": ""
                },
                {
                    "first": "JH",
                    "middle": [],
                    "last": "Davis",
                    "suffix": ""
                },
                {
                    "first": "JJ",
                    "middle": [],
                    "last": "Chou",
                    "suffix": ""
                },
                {
                    "first": "JW",
                    "middle": [],
                    "last": "Szostak",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "RNA",
            "volume": "12",
            "issn": "",
            "pages": "567-579",
            "other_ids": {
                "DOI": [
                    "10.1261/rna.2251306"
                ]
            }
        },
        "BIBREF84": {
            "title": "Design of a small molecule against an oncogenic noncoding RNA",
            "authors": [
                {
                    "first": "SP",
                    "middle": [],
                    "last": "Velagapudi",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Proc. Natl Acad. Sci. USA",
            "volume": "113",
            "issn": "",
            "pages": "5898-5903",
            "other_ids": {
                "DOI": [
                    "10.1073/pnas.1523975113"
                ]
            }
        },
        "BIBREF85": {
            "title": "Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "P\u00e9rot",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Sperandio",
                    "suffix": ""
                },
                {
                    "first": "MA",
                    "middle": [],
                    "last": "Miteva",
                    "suffix": ""
                },
                {
                    "first": "A-C",
                    "middle": [],
                    "last": "Camproux",
                    "suffix": ""
                },
                {
                    "first": "BO",
                    "middle": [],
                    "last": "Villoutreix",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Drug Discov. Today",
            "volume": "15",
            "issn": "",
            "pages": "656-667",
            "other_ids": {
                "DOI": [
                    "10.1016/j.drudis.2010.05.015"
                ]
            }
        },
        "BIBREF86": {
            "title": "The noncoding RNA revolution-trashing old rules to forge new ones",
            "authors": [
                {
                    "first": "TR",
                    "middle": [],
                    "last": "Cech",
                    "suffix": ""
                },
                {
                    "first": "JA",
                    "middle": [],
                    "last": "Steitz",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Cell",
            "volume": "157",
            "issn": "",
            "pages": "77-94",
            "other_ids": {
                "DOI": [
                    "10.1016/j.cell.2014.03.008"
                ]
            }
        },
        "BIBREF87": {
            "title": "Structure-based druggability assessment \u2014 identifying suitable targets for small molecule therapeutics",
            "authors": [
                {
                    "first": "EB",
                    "middle": [],
                    "last": "Fauman",
                    "suffix": ""
                },
                {
                    "first": "BK",
                    "middle": [],
                    "last": "Rai",
                    "suffix": ""
                },
                {
                    "first": "ES",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Curr. Opin. Chem. Biol.",
            "volume": "15",
            "issn": "",
            "pages": "463-468",
            "other_ids": {
                "DOI": [
                    "10.1016/j.cbpa.2011.05.020"
                ]
            }
        },
        "BIBREF88": {
            "title": "Pocketome via comprehensive identification and classification of ligand binding envelopes",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "An",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Totrov",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Abagyan",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Mol. Cell. Proteomics",
            "volume": "4",
            "issn": "",
            "pages": "752-761",
            "other_ids": {
                "DOI": [
                    "10.1074/mcp.M400159-MCP200"
                ]
            }
        },
        "BIBREF89": {
            "title": "Nuclear magnetic resonance structure of the III-IV-V three-way junction from the Varkud satellite ribozyme and identification of magnesium-binding sites using paramagnetic relaxation enhancement",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Bonneau",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Legault",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Biochemistry",
            "volume": "53",
            "issn": "",
            "pages": "6264-6275",
            "other_ids": {
                "DOI": [
                    "10.1021/bi500826n"
                ]
            }
        },
        "BIBREF90": {
            "title": "The NMR structure of the II-III-VI three-way junction from the Neurospora VS ribozyme reveals a critical tertiary interaction and provides new insights into the global ribozyme structure",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Bonneau",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Girard",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lemieux",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Legault",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "RNA",
            "volume": "21",
            "issn": "",
            "pages": "1621-1632",
            "other_ids": {
                "DOI": [
                    "10.1261/rna.052076.115"
                ]
            }
        },
        "BIBREF91": {
            "title": "Pseudoknots: RNA structures with diverse functions",
            "authors": [
                {
                    "first": "DW",
                    "middle": [],
                    "last": "Staple",
                    "suffix": ""
                },
                {
                    "first": "SE",
                    "middle": [],
                    "last": "Butcher",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "PLoS Biol.",
            "volume": "3",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1371/journal.pbio.0030213"
                ]
            }
        },
        "BIBREF92": {
            "title": "Solution structure of the pseudoknot of SRV-1 RNA, involved in ribosomal frameshifting",
            "authors": [
                {
                    "first": "PJ",
                    "middle": [],
                    "last": "Michiels",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J. Mol. Biol.",
            "volume": "310",
            "issn": "",
            "pages": "1109-1123",
            "other_ids": {
                "DOI": [
                    "10.1006/jmbi.2001.4823"
                ]
            }
        },
        "BIBREF93": {
            "title": "Accurate SHAPE-directed RNA secondary structure modeling, including pseudoknots",
            "authors": [
                {
                    "first": "CE",
                    "middle": [],
                    "last": "Hajdin",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Proc. Natl Acad. Sci. USA",
            "volume": "110",
            "issn": "",
            "pages": "5498-5503",
            "other_ids": {
                "DOI": [
                    "10.1073/pnas.1219988110"
                ]
            }
        },
        "BIBREF94": {
            "title": "Detection of RNA-protein interactions in living cells with SHAPE",
            "authors": [
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Smola",
                    "suffix": ""
                },
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Calabrese",
                    "suffix": ""
                },
                {
                    "first": "KM",
                    "middle": [],
                    "last": "Weeks",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Biochemistry",
            "volume": "54",
            "issn": "",
            "pages": "6867-6875",
            "other_ids": {
                "DOI": [
                    "10.1021/acs.biochem.5b00977"
                ]
            }
        },
        "BIBREF95": {
            "title": "Adaptive ligand binding by the purine riboswitch in the recognition of guanine and adenine analogs",
            "authors": [
                {
                    "first": "SD",
                    "middle": [],
                    "last": "Gilbert",
                    "suffix": ""
                },
                {
                    "first": "FE",
                    "middle": [],
                    "last": "Reyes",
                    "suffix": ""
                },
                {
                    "first": "AL",
                    "middle": [],
                    "last": "Edwards",
                    "suffix": ""
                },
                {
                    "first": "RT",
                    "middle": [],
                    "last": "Batey",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Structure",
            "volume": "17",
            "issn": "",
            "pages": "857-868",
            "other_ids": {
                "DOI": [
                    "10.1016/j.str.2009.04.009"
                ]
            }
        },
        "BIBREF96": {
            "title": "Validating fragment-based drug discovery for biological RNAs: lead fragments bind and remodel the TPP riboswitch specifically",
            "authors": [
                {
                    "first": "KD",
                    "middle": [],
                    "last": "Warner",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Chem. Biol.",
            "volume": "21",
            "issn": "",
            "pages": "591-595",
            "other_ids": {
                "DOI": [
                    "10.1016/j.chembiol.2014.03.007"
                ]
            }
        },
        "BIBREF97": {
            "title": "Landscape of transcription in human cells",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Djebali",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Nature",
            "volume": "489",
            "issn": "",
            "pages": "101-108",
            "other_ids": {
                "DOI": [
                    "10.1038/nature11233"
                ]
            }
        },
        "BIBREF98": {
            "title": "RNA structure: advances and assessment of 3D structure prediction",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Miao",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Westhof",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Annu. Rev. Biophys.",
            "volume": "46",
            "issn": "",
            "pages": "483-503",
            "other_ids": {
                "DOI": [
                    "10.1146/annurev-biophys-070816-034125"
                ]
            }
        },
        "BIBREF99": {
            "title": "Regulation of translation via mRNA structure in prokaryotes and eukaryotes",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kozak",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Gene",
            "volume": "361",
            "issn": "",
            "pages": "13-37",
            "other_ids": {
                "DOI": [
                    "10.1016/j.gene.2005.06.037"
                ]
            }
        },
        "BIBREF100": {
            "title": "Inhibition of translation by RNA-small molecule interactions",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Harvey",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Garneau",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Pelletier",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "RNA",
            "volume": "8",
            "issn": "",
            "pages": "452-463",
            "other_ids": {
                "DOI": [
                    "10.1017/S135583820202633X"
                ]
            }
        },
        "BIBREF101": {
            "title": "Novel 5\u2032 untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's disease",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bandyopadhyay",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "PLoS ONE",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1371/journal.pone.0065978"
                ]
            }
        },
        "BIBREF102": {
            "title": "Precise small-molecule recognition of a toxic CUG RNA repeat expansion",
            "authors": [
                {
                    "first": "SG",
                    "middle": [],
                    "last": "Rzuczek",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Nat. Chem. Biol.",
            "volume": "13",
            "issn": "",
            "pages": "188-193",
            "other_ids": {
                "DOI": [
                    "10.1038/nchembio.2251"
                ]
            }
        },
        "BIBREF103": {
            "title": "How RNA folds",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Tinoco",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Bustamante",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "J. Mol. Biol.",
            "volume": "293",
            "issn": "",
            "pages": "271-281",
            "other_ids": {
                "DOI": [
                    "10.1006/jmbi.1999.3001"
                ]
            }
        },
        "BIBREF104": {
            "title": "Lead- and drug-like compounds: the rule-of-five revolution",
            "authors": [
                {
                    "first": "CA",
                    "middle": [],
                    "last": "Lipinski",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Drug Discov. Today Technol.",
            "volume": "1",
            "issn": "",
            "pages": "337-341",
            "other_ids": {
                "DOI": [
                    "10.1016/j.ddtec.2004.11.007"
                ]
            }
        },
        "BIBREF105": {
            "title": "How drug-like are 'ugly' drugs: do drug-likeness metrics predict ADME behaviour in humans?",
            "authors": [
                {
                    "first": "TJ",
                    "middle": [],
                    "last": "Ritchie",
                    "suffix": ""
                },
                {
                    "first": "SJF",
                    "middle": [],
                    "last": "Macdonald",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Drug Discov. Today",
            "volume": "19",
            "issn": "",
            "pages": "489-495",
            "other_ids": {
                "DOI": [
                    "10.1016/j.drudis.2014.01.007"
                ]
            }
        },
        "BIBREF106": {
            "title": "Slow molecular recognition by RNA",
            "authors": [
                {
                    "first": "KR",
                    "middle": [],
                    "last": "Gleitsman",
                    "suffix": ""
                },
                {
                    "first": "RN",
                    "middle": [],
                    "last": "Sengupta",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Herschlag",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "RNA",
            "volume": "23",
            "issn": "",
            "pages": "1745-1753",
            "other_ids": {
                "DOI": [
                    "10.1261/rna.062026.117"
                ]
            }
        },
        "BIBREF107": {
            "title": "RNA recognition by Tat-derived peptides: interaction in the major groove?",
            "authors": [
                {
                    "first": "KM",
                    "middle": [],
                    "last": "Weeks",
                    "suffix": ""
                },
                {
                    "first": "DM",
                    "middle": [],
                    "last": "Crothers",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "Cell",
            "volume": "66",
            "issn": "",
            "pages": "577-588",
            "other_ids": {
                "DOI": [
                    "10.1016/0092-8674(81)90020-9"
                ]
            }
        }
    }
}